Veracyte is trading 20.89% lower at $34.30 after-hours, following a September 22, 2026 close at $43.36; available coverage identifies no new company-specific announcement explaining the decline. - Acquisition and conference news were dated September 14–15. - Broader markets were mixed, leaving the catalyst unclear.